Erastin
目录号:S7242 Purity: 99.89%
此产品在溶液中不稳定,请现配现用!
Erastin是一种ferroptosis激活剂,通过作用于线粒体VDAC而起作用,选择性作用于携带致癌基因RAS的肿瘤细胞。在溶液中不稳定,请现配现用!
CAS: 571203-78-6
客户使用Selleck的Erastin发表文献421篇
- Cell Metab, 2024 S1550-4131(24)00371-1
- Cell Metab, 2024 S1550-4131(24)00456-X
- Cell, 2023 186(13):2748-2764.e22
- Signal Transduct Target Ther, 2023 8(1):194
- Drug Resist Updat, 2023 70:100985
- Signal Transduct Target Ther, 2022 7(1):59
- Cell Metab, 2022 34(1):90-105.e7
- Cell Metab, 2022 S1550-4131-2200411-9
- Nat Cell Biol, 2022 24(1):88-98
- Cell Metab, 2021 S1550-4131(21)00233-3
- Cancer Discov, 2021 candisc.0936.2020
- Gut, 2021 70(5):890-899
- Nat Immunol, 2020 21(7):727-735
- Cell, 2019 36(2):179-193
- Cancer Cell, 2019 36(2):179-193
- Cell Metab, 2019 29(5):1217-1231
- Cancer Cell, 2018 33(5):890-904.e5
- Gastroenterology, 2018 154(5):1480-1493
- Nature, 2017 551(7682):639-643
- Gastroenterology, 2017 153(5):1429-1443
- Nat Commun, 2024 15(1):1429
- Nat Commun, 2024 15(1):7522
- Nat Commun, 2024 15(1):4114
- Adv Sci (Weinh), 2024 11(40):e2402671
- Cell Death Differ, 2024 10.1038/s41418-024-01324-3
- Theranostics, 2024 14(10):4090-4106
- Genome Biol, 2024 25(1):58
- Redox Biol, 2024 75:103270
- Redox Biol, 2024 75:103299
- Redox Biol, 2024 69:103002
- Redox Biol, 2024 72:103137
- Redox Biol, 2024 75:103293
- Redox Biol, 2024 70:103039
- Redox Biol, 2024 73:103182
- Redox Biol, 2024 72:103160
- Redox Biol, 2024 77:103360
- Redox Biol, 2024 76:103304
- J Nanobiotechnology, 2024 22(1):662
- Cancer Lett, 2024 604:217258
- Int J Biol Sci, 2024 20(12):4635-4653
- Int J Biol Sci, 2024 20(5):1707-1728
- Cell Death Dis, 2024 15(3):178
- Cell Death Dis, 2024 15(11):861
- Cell Death Dis, 2024 15(3):182
- Cell Death Dis, 2024 15(6):398
- Cell Rep, 2024 43(7):114477
- Cell Commun Signal, 2024 22(1):431
- Cell Mol Life Sci, 2024 81(1):122
- Biomed Pharmacother, 2024 174:116547
- J Transl Med, 2024 22(1):723
- Antioxidants (Basel), 2024 13(1)114
- Cell Death Discov, 2024 10(1):135
- Antioxidants (Basel), 2024 13(2)182
- Cell Death Discov, 2024 10(1):253
- Antioxidants (Basel), 2024 13(7)757
- Eur J Med Chem, 2024 276:116670
- Oncogenesis, 2024 13(1):31
- Cell Biol Toxicol, 2024 40(1):99
- Cell Biol Toxicol, 2024 40(1):3
- Am J Pathol, 2024 S0002-9440(24)00356-0
- Cells, 2024 13(18)1541
- iScience, 2024 27(11):111169
- Mol Med, 2024 30(1):182
- Front Pharmacol, 2024 15:1409321
- Virol Sin, 2024 39(1):144-155
- Biomolecules, 2024 14(4)422
- CNS Neurosci Ther, 2024 30(8):e14911
- J Virol, 2024 98(3):e0189723
- J Ethnopharmacol, 2024 328:118076
- J Ethnopharmacol, 2024 326:117937
- J Ethnopharmacol, 2024 318(Pt B):116983
- J Cell Mol Med, 2024 28(1):e17983
- J Cell Mol Med, 2024 28(18):e70103
- Mol Neurobiol, 2024 10.1007/s12035-024-04497-7
- Hepatol Commun, 2024 8(3)e0396
- Chem Biol Interact, 2024 395:111016
- Transl Oncol, 2024 41:101877
- J Mol Cell Cardiol, 2024 196:71-83
- Eur J Pharmacol, 2024 971:176544
- J Biol Chem, 2024 300(12):107942
- J Biol Chem, 2024 S0021-9258(24)01266-3
- Sci Rep, 2024 14(1):20770
- Bone Joint Res, 2024 13(3):110-123
- World J Gastroenterol, 2024 30(5):485-498
- J Immunol Res, 2024 2024:9943747
- Heliyon, 2024 10(11):e32571
- BMC Complement Med Ther, 2024 24(1):193
- Toxicol Appl Pharmacol, 2024 486:116936
- PLoS One, 2024 19(10):e0311922
- J Cancer Res Clin Oncol, 2024 150(5):228
- J Cancer Res Clin Oncol, 2024 150(4):204
- Mol Med Rep, 2024 30(1)118
- Kaohsiung J Med Sci, 2024 10.1002/kjm2.12889
- Biochem Biophys Res Commun, 2024 740:151015
- Biochemistry, 2024 63(8):984-999
- Cancer Drug Resist, 2024 7:44
- bioRxiv, 2024 2024.05.13.593939
- Nat Commun, 2023 14(1):1430
- Nat Commun, 2023 14(1):7598
- Nat Commun, 2023 14(1):3673
- Nat Commun, 2023 14(1):5728
- Adv Sci (Weinh), 2023 10(25):e2300414
- Adv Sci (Weinh), 2023 10(6):e2204006
- Adv Sci (Weinh), 2023 10(3):e2203718
- Adv Sci (Weinh), 2023 10(25):e2301088
- Cell Rep Med, 2023 4(12):101339
- Cell Death Differ, 2023 30(8):1988-2004
- Redox Biol, 2023 65:102825
- Redox Biol, 2023 62:102678
- Redox Biol, 2023 66:102858
- Redox Biol, 2023 62:102708
- J Adv Res, 2023 S2090-1232(23)00063-2
- Clin Transl Med, 2023 13(12):e1494
- PLoS Biol, 2023 21(7):e3001862
- Cell Death Dis, 2023 14(9):634
- Cell Death Dis, 2023 14(7):402
- Cell Death Dis, 2023 14(8):532
- Cell Death Dis, 2023 14(10):680
- Cell Death Dis, 2023 10.1038/s41419-023-06284-z
- Cell Death Dis, 2023 14(6):356
- Cell Rep, 2023 42(9):113023
- Biomed Pharmacother, 2023 164:114930
- J Transl Med, 2023 21(1):334
- J Transl Med, 2023 10.1186/s12967-023-04664-9
- Oxid Med Cell Longev, 2023 2023:9808100
- Cell Mol Gastroenterol Hepatol, 2023 16(1):133-159
- Cell Death Discov, 2023 9(1):456
- Antioxidants (Basel), 2023 12(12)2119
- Cell Death Discov, 2023 9(1):331
- Cell Death Discov, 2023 9(1):97
- Antioxidants -Basel), 2023 12(2)349
- Cell Death Discov, 2023 9(1):428
- Cell Death Discov, 2023 9(1):189
- J Orthop Translat, 2023 39:147-162
- Antioxid Redox Signal, 2023 39(1-3):166-185.
- Cells, 2023 12(2)310
- Cells, 2023 12(5)735
- Commun Biol, 2023 6(1):1108
- iScience, 2023 26(9):107647
- Mol Med, 2023 29(1):132
- J Cell Physiol, 2023 10.1002/jcp.31093
- Int J Mol Sci, 2023 24(19)14595
- Int J Mol Sci, 2023 24(11)9199
- Int Immunopharmacol, 2023 124(Pt A):110885
- Int J Mol Sci, 2023 24(23)16709
- Am J Cancer Res, 2023 13(11):5174-5196
- J Cell Mol Med, 2023 27(16):2340-2353
- Am J Cancer Res, 2023 13(11):5236-5253
- Cancers (Basel), 2023 15(6)1880
- Front Endocrinol (Lausanne), 2023 14:1172199
- Cancers (Basel), 2023 15(13)3484
- Chem Biol Interact, 2023 384:110712
- Transl Oncol, 2023 32:101649
- Transl Oncol, 2023 27:101576
- Front Oncol, 2023 13:1125855
- Sci Rep, 2023 13(1):17476
- Pharmaceuticals (Basel), 2023 16(9)1210
- Sci Rep, 2023 13(1):15004
- World J Stem Cells, 2023 15(11):1017-1034
- J Hepatocell Carcinoma, 2023 10:1-16
- Metabolites, 2023 13(2)142
- Heliyon, 2023 9(8):e18449
- Heliyon, 2023 9(7):e17849
- J Cancer, 2023 14(5):821-834
- BMC Cancer, 2023 23(1):179
- Exp Cell Res, 2023 424(1):113474
- Cancer Biol Ther, 2023 24(1):2223377
- BMC Mol Cell Biol, 2023 24(1):14
- BMC Gastroenterol, 2023 23(1):104
- Open Life Sci, 2023 18(1):20220678
- Open Med -Wars), 2023 18(1):20230809
- J Gastrointest Oncol, 2023 14(4):1715-1725
- Sci Adv, 2023 9(37):eadi5192
- Discov Oncol, 2023 14(1):42
- Discov Oncol, 2023 14(1):107
- Bioact Mater, 2022 18:459-470
- Mol Cell, 2022 82(5):920-932.e7
- Adv Sci (Weinh), 2022 9(28):e2203357
- Cell Death Differ, 2022 10.1038/s41418-022-01089-7
- Cell Death Differ, 2022 10.1038/s41418-022-00970-9
- Cell Death Differ, 2022 10.1038/s41418-022-00977-2
- Cell Death Differ, 2022 10.1038/s41418-022-01008-w
- Redox Biol, 2022 58:102546
- Redox Biol, 2022 52:102317
- Redox Biol, 2022 57:102493
- Redox Biol, 2022 56:102451
- J Exp Clin Cancer Res, 2022 41(1):284
- J Exp Clin Cancer Res, 2022 41(1):79
- Cancer Res, 2022 82(12):2254-2268
- Cancer Res, 2022 canres.0218.2021
- Proc Natl Acad Sci U S A, 2022 119(36):e2117396119
- Mol Psychiatry, 2022 10.1038/s41380-022-01568-w
- Adv Healthc Mater, 2022 e2202009
- Int J Biol Sci, 2022 18(2):841-857
- Cell Death Dis, 2022 13(10):912
- Cell Death Dis, 2022 13(11):1010
- Cell Death Dis, 2022 13(11):1000
- Cell Death Dis, 2022 13(8):704
- Cell Death Dis, 2022 13(10):861
- Cell Death Dis, 2022 13(12):1072
- Cell Death Dis, 2022 13(2):150
- Cell Death Dis, 2022 13(7):592
- Cell Death Dis, 2022 13(6):521
- Food Chem, 2022 377:132051
- Mol Metab, 2022 57:101436
- Cell Mol Life Sci, 2022 79(5):228
- Cell Biosci, 2022 12(1):20
- Stem Cell Res Ther, 2022 13(1):260
- Cell Biosci, 2022 12(1):53
- Biomed Pharmacother, 2022 148:112742
- Free Radic Biol Med, 2022 181:288-299
- Free Radic Biol Med, 2022 182:219-231
- Free Radic Biol Med, 2022 189:42-57
- Oxid Med Cell Longev, 2022 2022:3846217
- Oxid Med Cell Longev, 2022 2022:8091464
- Br J Pharmacol, 2022 10.1111/bph.15834
- Antioxidants (Basel), 2022 11(11)2221
- Cell Death Discov, 2022 8(1):201
- Cell Death Discov, 2022 8(1):414
- Antioxidants (Basel), 2022 11(8)1602
- Cells, 2022 12(1)99
- Commun Biol, 2022 5(1):47
- Commun Biol, 2022 5(1):593
- Cancer Cell Int, 2022 22(1):326
- J Cell Physiol, 2022 10.1002/jcp.30863
- Int J Mol Sci, 2022 23(16)9014
- Front Pharmacol, 2022 13:865689
- Int J Mol Sci, 2022 23(24)16205
- Front Pharmacol, 2022 13:791376
- Front Pharmacol, 2022 13:902102
- Front Pharmacol, 2022 13:988335
- J Cell Mol Med, 2022 10.1111/jcmm.17241
- Mol Cell Biol, 2022 e0052221
- Cancers (Basel), 2022 14(21)5233
- Cancers (Basel), 2022 14(14)3410
- Cancers (Basel), 2022 14(20)5050
- Cancers (Basel), 2022 14(19)4690
- Bioengineered, 2022 13(4):11187-11207
- Bioengineered, 2022 13(2):4063-4075
- FASEB J, 2022 36(12):e22649
- Drug Des Devel Ther, 2022 16:2083-2099
- Virol J, 2022 19(1):104
- Front Oncol, 2022 12:939605
- Int Immunopharmacol, 2022 113(Pt B):109422
- Molecules, 2022 27(20)7088
- Sci Rep, 2022 12(1):9024
- J Oncol, 2022 2022:4250531
- Drug Dev Res, 2022 10.1002/ddr.21983
- Cell Stress Chaperones, 2022 10.1007/s12192-022-01257-1
- Asian J Surg, 2022 S1015-9584(21)00789-2
- Anal Cell Pathol (Amst), 2022 2022:4213401
- Anal Cell Pathol (Amst), 2022 2022:2843990
- Biochem Biophys Res Commun, 2022 622:37-44
- J Mol Neurosci, 2022 10.1007/s12031-022-02017-7
- Biochem Biophys Res Commun, 2022 606:68-74
- Prostate, 2022 10.1002/pros.24308
- Exp Ther Med, 2022 24(2):502
- FEBS Open Bio, 2022 10.1002/2211-5463.13393
- Comput Math Methods Med, 2022 2022:8509626
- Am J Transl Res, 2022 14(12):8473-8488
- Cell Death & Disease, 2022 592-2022)
- Nat Commun, 2021 12(1):5147
- Nat Commun, 2021 12(1):647
- Biomaterials, 2021 277:121100
- Autophagy, 2021 1-14
- Autophagy, 2021 10.1080/15548627.2021.2008692
- Mol Ther, 2021 29(1):263-274
- Cell Death Differ, 2021 28(8):2536-2551
- Redox Biol, 2021 45:102045
- Redox Biol, 2021 47:102151
- Redox Biol, 2021 43:102006
- Redox Biol, 2021 S2213-2317(21)00076-8
- Redox Biol, 2021 38:101807
- J Exp Clin Cancer Res, 2021 40(1):350
- J Exp Clin Cancer Res, 2021 40(1):190
- Cancer Res, 2021 81(20):5217-5229
- Cancer Res, 2021 canres.1547.2021
- EMBO Mol Med, 2021 e13792
- Clin Transl Med, 2021 11(4):e390
- Haematologica, 2021 10.3324/haematol.2020.259531
- Cancer Lett, 2021 527:28-40
- Cell Death Dis, 2021 12(7):699
- Cell Death Dis, 2021 12(2):160
- Cell Death Dis, 2021 12(11):1028
- Cell Death Dis, 2021 12(9):839
- Cell Death Dis, 2021 12(9):834
- Cell Rep, 2021 34(8):108767
- Cell Mol Biol Lett, 2021 26(1):26
- Acta Pharmacol Sin, 2021 10.1038/s41401-020-00600-5
- Phytomedicine, 2021 90:153641
- Elife, 2021 10e64806
- Free Radic Biol Med, 2021 168:25-43
- Anal Chem, 2021 93(50):16887-16898
- Oxid Med Cell Longev, 2021 2021:7007933
- Br J Pharmacol, 2021 178(5):1182-1199
- Phytother Res, 2021 10.1002/ptr.7353
- Antioxidants (Basel), 2021 10(6)976
- Antioxidants (Basel), 2021 10(9)1347
- Cell Death Discov, 2021 7(1):334
- Cell Death Discov, 2021 7(1):374
- Mol Oncol, 2021 10.1002/1878-0261.12936
- Life Sci, 2021 276:119399
- iScience, 2021 24(8):102837
- Neurotherapeutics, 2021 10.1007/s13311-021-01111-9
- Int J Mol Sci, 2021 22(22)12234
- Int J Mol Sci, 2021 22(16)8898
- Int Immunopharmacol, 2021 95:107552
- Biomolecules, 2021 12(1)48
- Front Cell Dev Biol, 2021 9:698679
- Front Cell Dev Biol, 2021 9:719187
- Int J Mol Med, 2021 47(1):289-301
- Biochim Biophys Acta Mol Cell Res, 2021 1868(2):118913
- J Mol Cell Cardiol, 2021 150:65-76
- Drug Des Devel Ther, 2021 15:3965-3978
- Hum Cell, 2021 10.1007/s13577-021-00645-6
- Hum Cell, 2021 10.1007/s13577-021-00557-5
- Pharmgenomics Pers Med, 2021 14:927-945
- Biomol Ther (Seoul), 2021 10.4062/biomolther.2021.105
- Front Genet, 2021 12:774400
- Gene, 2021 S0378-1119(21)00587-4
- Mol Med Rep, 2021 24(4)713
- Free Radic Res, 2021 1-18
- Free Radic Res, 2021 1-22
- Toxicol In Vitro, 2021 73:105146
- Biochem Biophys Res Commun, 2021 583:56-62
- Biochem Biophys Res Commun, 2021 567:92-98
- Biochem Biophys Res Commun, 2021 576:33-39
- Biochem Biophys Res Commun, 2021 562:55-61
- Biochem Biophys Res Commun, 2021 575:1-7
- Biochem Biophys Res Commun, 2021 566:9-15
- Biochem Biophys Res Commun, 2021 536:100-106
- Sci Adv, 2021 7(22)eabg4302
- Sci Adv, 2021 7(35)eabj0364
- bioRxiv, 2021 10.1101/2021.04.07.438684
- Nat Commun, 2020 23;11(1):433
- Nat Chem Biol, 2020 6
- Autophagy, 2020 18;1-13
- Cell Death Differ, 2020 10.1038/s41418-020-00689-5
- Redox Biol, 2020 36:101619
- Redox Biol, 2020 32:101483
- Genes Dev, 2020 34(7-8):526-543
- Cell Death Dis, 2020 11(3):192
- Cell Death Dis, 2020 11(9):781
- Cell Death Dis, 2020 11(8):641
- Cell Rep, 2020 31(12):107800
- Food Chem, 2020 315:126236
- Acta Pharmacol Sin, 2020 10.1038/s41401-020-00531-1
- Apoptosis, 2020 10.1007/s10495-020-01627-z
- Apoptosis, 2020 21
- Cell Death Discov, 2020 6(1):119
- Arch Toxicol, 2020 10.1007/s00204-020-02826-y
- Neural Regen Res, 2020 15(8):1539-1545
- Life Sci, 2020 266:118905
- J Cell Physiol, 2020 24
- J Cell Physiol, 2020 10.1002
- Front Pharmacol, 2020 11:601572
- ALTEX, 2020 10.14573/altex.1911111
- Front Cell Dev Biol, 2020 8:538
- Aging (Albany NY), 2020 12(18):17800-17814
- Cell Signal, 2020 10;72:109633
- Front Oncol, 2020 10:1656
- Sci Rep, 2020 10(1):959
- Cell Biol Int, 2020 44(11):2344-2356
- Gene, 2020 755:144889
- Toxicol Mech Methods, 2020 1-10
- Biochem Biophys Res Commun, 2020 523(4):966-971
- Biochem Biophys Res Commun, 2020 533(4):1464-1469
- Oncol Lett, 2020 20(4):57
- Anticancer Drugs, 2020 31(1):27-34
- Sci Adv, 2020 25;6(13):eaay9789
- Theranostics, 2019 9(11):3293-3307
- Cell Death Differ, 2019 10.1038/s41418-019-0338-1
- Cell Death Differ, 2019 26(11):2329-2343
- Dev Cell, 2019 10.1016/j.devcel.2019.10.007
- Cancer Res, 2019 79(20):5355-5366
- Acta Pharmacol Sin, 2019 10.1038/s41401-019-0233-9
- Elife, 2019 10.7554/eLife.48828
- J Invest Dermatol, 2019 139(9):1925-1935.e5
- Cells, 2019 8(8)
- Front Pharmacol, 2019 10:638
- J Cell Physiol, 2019 10.1002/jcp.29017
- J Cell Mol Med, 2019 23(11):7349-7359
- Am J Cancer Res, 2019 9(4):730-739
- J Biol Chem, 2019 294(50):19395-19404
- Cell Cycle, 2019 18(8):773-783
- J Cell Biochem, 2019 120(1):928-939
- RSC Adv, 2019 9(49):28548-28553
- Toxicol Appl Pharmacol, 2019 379:114665
- J Pharmacol Exp Ther, 2019 369(1):47-54
- eNeuro, 2019 6(1)
- Free Radic Res, 2019 53(1):104-114
- Biochem Biophys Res Commun, 2019 10.1016/j.bbrc.2019.11.110
- Biochem Biophys Res Commun, 2019 510(2):278-283
- DNA Cell Biol, 2019 10.1089/dna.2019.5097
- Oncol Lett, 2019 17(3):3001-3008
- J Clin Invest, 2018 128(8):3341-3355
- Autophagy, 2018 14(12):2083-2103
- Curr Biol, 2018 28(15):2388-2399
- Free Radic Biol Med, 2018 129:454-462
- Cancer Sci, 2018 109(9):2757-2766
- Cancer Res Treat, 2018 50(2):445-460
- Biochem Biophys Res Commun, 2018 503(3):1689-1695
- Nat Commun, 2017 8:14844
- Cancer Res, 2017 canres.1979.2016
- Cell Rep, 2017 20(7):1692-1704
- Oncogene, 2017 36(29):4089-4099
- Oncotarget, 2017 8(70):115164-115178
- Biochem Biophys Res Commun, 2017 491(4):919-925
- Hepatology, 2016 63(1):173-84
- Hepatology, 2016 64(2):488-500
- Oncotarget, 2016 7(11):11756-69
- Oncotarget, 2016 7(14):18050-64
- PLoS One, 2016 11(5):e0154605
- Biochem Biophys Res Commun, 2016 478(3):1338-43
- Biochem Biophys Res Commun, 2016 473(4):775-80
- Biochem Biophys Res Commun, 2016 480(3):443-449
- Biochem Biophys Res Commun, 2016 480(4):602-607
- Biochem Biophys Res Commun, 2016 478(2):838-44
- Cell Death Dis, 2015 6:e1601
- Oncogene, 2015 10.1038/onc.2015.32
- Mol Cell Oncol, 2015 2(4):e1054549
化学信息&溶解度
分子量 | 547.04 |
分子式 | C30H31ClN4O4 |
CAS号 | 571203-78-6 |
Smiles | CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl |
储存条件(自收到货起) | 3年 -20°C 粉状 |
此产品性质不稳定,需现配现用!建议您购买分装规格,或者在收到货后进行分装。 |
体外溶解度 | 批次: |
DMSO : 25 mg/mL ( 45.7 mM; Warmed with 50℃ water bath; Ultrasonicated; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 15 mg/mL ( 27.42 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 15 mg/mL ( 27.42 mM; Warmed with 50℃ water bath; Ultrasonicated; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 13 mg/mL ( 23.76 mM; Warmed with 50℃ water bath; Ultrasonicated; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
10%DMSO
40%PEG300
5%Tween80
45%ddH2O
浓度:1.67mg/ml
(3.05mM)
操作示例:以 1 mL 工作液为例,取100μL16.67mg/ml的澄清DMSO储备液加到400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入450μL ddH2O定容至 1 mL。工作液请现配现用!
|
|
10%DMSO
90%Corn oil
浓度:2.5mg/ml
(4.57mM)
操作示例:以 1 mL 工作液为例,取100μL25mg/ml的澄清DMSO储备液加到900μL玉米油中,混合均匀。工作液请现配现用!
|
|
5%DMSO
40%PEG300
5%Tween80
50%ddH2O
浓度:1mg/ml
(1.83mM)
操作示例:以 1 mL 工作液为例,取50μL20mg/ml的澄清DMSO储备液加到400μLPEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μLddH2O定容至1mL。工作液请现配现用!
|
|
5% DMSO
95% Corn oil
浓度:0.5mg/ml
(0.91mM)
操作示例:以1 mL工作液为例,取50μL 10mg/ml的澄清DMSO储备液加到950μL玉米油中,混合均匀。工作液请现配现用!
|
|
10%DMSO
40%PEG300
5%Tween80
45%ddH2O
浓度:0.8mg/ml
(1.46mM)
操作示例:以 1 mL 工作液为例,取100μL8mg/ml的澄清DMSO储备液加到400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入450μL ddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。